http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105294840-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105294840-B |
| titleOfInvention | A kind of peptide fragment for preventing and treating the infection of intestines pathogenic escherichia coli |
| abstract | The present invention provides a kind of polypeptides for preventing and treating the infection of intestines pathogenic escherichia coli comprising SEQ ID NO：1、SEQ ID NO：2、SEQ ID NO：3 or SEQ ID NO：4 amino acid sequence.Technical solution using the present invention, the affinity for the polypeptide and EspB albumen that prevent and treat the infection of intestines pathogenic escherichia coli is higher than reference protein, can be used for preventing and treating the polypeptide of intestines pathogenic escherichia coli infection can inhibit the adherency of EPEC and 2 cells of HEp, block the function of EspB, to reduce absorption of the EPEC to epithelial cell, new direction is provided for EPEC treatments, the drug for research and development prevention and treatment EPEC is laid a good foundation. |
| priorityDate | 2015-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 22.